Nicotinamide Phosphoribosyltransferase May Be Involved in Age-Related Brain Diseases

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Liu, Li Ying ^a   Wang, Feng ^a   Zhang, Xia Yan ^a   Huang, Peng ^a   Lu, Yun Bi ^a   Wei, Er Qing ^a   Zhang, Wei Ping ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DAPORINAD; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN DISEASE; BRAIN ISCHEMIA; BRAIN LEVEL; CELL LEVEL; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; HIPPOCAMPUS; MICROGLIA; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; RAT;

ACRYLAMIDES; AGING; ANIMALS; BRAIN DISEASES; CEREBELLUM; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; MICE; NAD; NEURONS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PIPERIDINES; RATS;

EID: 84867417683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044933     Document Type: Article

References (46)

1. Rongvaux A, Shea RJ, Mulks MH, Gigot D, Urbain J, et al. (2002) Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 32: 3225-3234.
2. Wang P, Xu TY, Guan YF, Tian WW, Viollet B, et al. (2011) Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol 69: 360-374.
3. Zhang W, Xie Y, Wang T, Bi J, Li H, et al. (2010) Neuronal protective role of PBEF in a mouse model of cerebral ischemia. J Cereb Blood Flow Metab 30: 1962-1971.
4. Tao R, Wei D, Gao H, Liu Y, Depinho RA, et al. (2011) Hepatic FoxOs Regulate Lipid Metabolism via Modulation of Expression of the Nicotinamide Phosphoribosyltransferase Gene. J Biol Chem 286: 14681-14690.
5. Samal B, Sun Y, Stearns G, Xie C, Suggs S, et al. (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14: 1431-1437.
6. Koltai E, Szabo Z, Atalay M, Boldogh I, Naito H, et al. (2010) Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech Ageing Dev 131: 21-28.
7. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, et al. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307: 426-430.
8. Kitani T, Okuno S, Fujisawa H, (2003) Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett 544: 74-78.
9. Belenky P, Bogan KL, Brenner C, (2007) NAD(+) metabolism in health and disease. Trends in Biochemical Sciences 32: 12-19.
10. Garten A, Petzold S, Korner A, Imai S, Kiess W, (2009) Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol Metab 20: 130-138.
11. Hara N, Yamada K, Shibata T, Osago H, Tsuchiya M, (2011) Nicotinamide phosphoribosyltransferase/visfatin does not catalyze nicotinamide mononucleotide formation in blood plasma. PLoS One 6: e22781.
12. Ho C, van der Veer E, Akawi O, Pickering JG, (2009) SIRT1 markedly extends replicative lifespan if the NAD+ salvage pathway is enhanced. FEBS Lett 583: 3081-3085.
13. Imai S, (2009) The NAD World: a new systemic regulatory network for metabolism and aging-Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys 53: 65-74.
14. Yang H, Lavu S, Sinclair DA, (2006) Nampt/PBEF/Visfatin: a regulator of mammalian health and longevity? Exp Gerontol 41: 718-726.
15. Hsu CP, Odewale I, Alcendor RR, Sadoshima J, (2008) Sirt1 protects the heart from aging and stress. Biol Chem 389: 221-231.
16. van der Veer E, Ho C, O'Neil C, Barbosa N, Scott R, et al. (2007) Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem 282: 10841-10845.
17. Moschen AR, Gerner RR, Tilg H, (2010) Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Curr Pharm Des 16: 1913-1920.
18. Garten A, Petzold S, Schuster S, Korner A, Kratzsch J, et al. (2011) Nampt and its potential role in inflammation and type 2 diabetes. Handb Exp Pharmacol pp. 147-164.
19. Bi TQ, Che XM, (2010) Nampt/PBEF/visfatin and cancer. Cancer Biol Ther 10: 119-125.
20. Busso N, Karababa M, Nobile M, Rolaz A, Van Gool F, et al. (2008) Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One 3: e2267.
21. Wang P, Vanhoutte PM, Miao CY, (2011) Visfatin and cardio-cerebro-vascular disease. J Cardiovasc Pharmacol 59: 1-9.
22. Oita RC, Ferdinando D, Wilson S, Bunce C, Mazzatti DJ, (2010) Visfatin induces oxidative stress in differentiated C2C12 myotubes in an Akt- and MAPK-independent, NFkB-dependent manner. Pflugers Arch 459: 619-630.
23. Jia SH, Li Y, Parodo J, Kapus A, Fan L, et al. (2004) Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113: 1318-1327.
24. Dahl TB, Holm S, Aukrust P, Halvorsen B, (2012) Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and Pathophysiology. Annu Rev Nutr [Epub ahead of print].
25. Hertz L, (2008) Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology 55: 289-309.
26. Jurgens HA, Johnson RW, (2012) Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation. Exp Neurol 233: 40-48.
27. Shankar SK, (2010) Biology of aging brain. Indian J Pathol Microbiol 53: 595-604.
28. Adeghate E, (2008) Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Curr Med Chem 15: 1851-1862.
29. Yang H, Yang T, Baur JA, Perez E, Matsui T, et al. (2007) Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130: 1095-1107.
30. Wang J, He Z, (2009) NAD and axon degeneration: from the Wlds gene to neurochemistry. Cell Adh Migr 3: 77-87.
31. Revollo JR, Grimm AA, Imai S, (2007) The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 23: 164-170.
32. Liu P, Li H, Cepeda J, Xia Y, Kempf JA, et al. (2009) Regulation of inflammatory cytokine expression in pulmonary epithelial cells by pre-B-cell colony-enhancing factor via a nonenzymatic and AP-1-dependent mechanism. J Biol Chem 284: 27344-27351.
33. Chen MP, Chung FM, Chang DM, Tsai JC, Huang HF, et al. (2006) Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91: 295-299.
34. Reddy PS, Umesh S, Thota B, Tandon A, Pandey P, et al. (2008) PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value. Cancer Biol Ther 7: 663-668.
35. Filippatos TD, Randeva HS, Derdemezis CS, Elisaf MS, Mikhailidis DP, (2009) Visfatin/PBEF and atherosclerosis-related diseases. Curr Vasc Pharmacol 8: 12-28.
36. Dahl T, Ranheim T, Holm S, Berge R, Aukrust P, et al. (2011) Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages. Eur J Clin Invest 41: 1098-1104.
37. Malam Z, Parodo J, Waheed F, Szaszi K, Kapus A, et al. (2011) Pre-B cell colony-enhancing factor (PBEF/Nampt/visfatin) primes neutrophils for augmented respiratory burst activity through partial assembly of the NADPH oxidase. J Immunol 186: 6474-6484.
38. Rongvaux A, Galli M, Denanglaire S, Van Gool F, Dreze PL, et al. (2008) Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress. J Immunol 181: 4685-4695.
39. Esposito E, Impellizzeri D, Mazzon E, Fakhfouri G, Rahimian R, et al. (2012) The NAMPT inhibitor FK866 reverts the damage in spinal cord injury. J Neuroinflammation 9: 66-76.
40. Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Poljak A, et al. (2011) Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One 6: e19194.
41. Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, et al. (2004) Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci 61: 19-34.
42. Belenky P, Bogan KL, Brenner C, (2007) NAD+ metabolism in health and disease. Trends Biochem Sci 32: 12-19.
43. Magni G, Orsomando G, Raffelli N, Ruggieri S, (2008) Enzymology of mammalian NAD metabolism in health and disease. Front Biosci 13: 6135-6154.
44. Bi J, Li H, Ye SQ, Ding S, (2011) Pre-B-cell colony-enhancing factor exerts a neuronal protection through its enzymatic activity and the reduction of mitochondrial dysfunction in in vitro ischemic models. J Neurochem 120: 334-346.
45. Boini KM, Zhang C, Xia M, Han WQ, Brimson C, et al. Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells. Biochim Biophys Acta 1801: 1294-1304.
46. Wassink AM, Olijhoek JK, Visseren FL, (2007) The metabolic syndrome: metabolic changes with vascular consequences. Eur J Clin Invest 37: 8-17.